Hypera Pharma

Hypera Pharma (formerly known as Hypermarcas) is a Brazilian multinational pharmaceutical company headquartered in São Paulo. It is the Brazilian largest pharmaceutical company by market capitalization. The company was formerly known as Hypermarcas, before a corporate name change that was announced in December 2017.[2] The company was rebranded as Hypera in 2018.[3][4]

Hypera S.A.
Formerly
  • Prátika Industrial
    (2001–2008)
  • Hipermarcas S.A.
    (2008–2018)
TypeSociedade Anônima
Ibovespa Component
IndustryPharmaceuticals
Founded2001 (2001)
HeadquartersSão Paulo, Brazil
Key people
Breno Oliveira,(CEO)
ProductsDrugs
Healthcare
Cosmetics
RevenueIncrease US$ 1.1 billion (2017)[1]
Decrease US$ 297.8 million (2017)[1]
Number of employees
7,515 (Dec 31, 2019)
SubsidiariesMantecorp
Websitewww.hyperapharma.com.br

Hypera Pharma's main market segments are Consumer Health, Branded Prescription and Branded Generics.

References
  1. Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine
  2. "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Brazilian Portuguese). 2017-12-04.
  3. Imprensa, Assessoria (2018-01-02). "Hypermarcas muda o nome para Hypera Pharma e quer crescer acima do mercado". Febrafar (in Brazilian Portuguese). Retrieved 2023-03-28.
  4. "Hypera Pharma passa a ser o novo nome da Hypermarcas". Valor Econômico (in Brazilian Portuguese). Retrieved 2023-03-28.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.